Nathan R. Rose
- Molecular Biology top 2%
- Cancer Research top 2%
- Genetics top 5%
- Oncology top 10%
- Genetics top 5%
- Co-authors
- Robert J. KloseChristopher J. SchofieldM.A. McDonoughOliver N. F. KingAkane KawamuraNeil P. BlackledgeUdo OppermannStanley S. Ng
- Topics
- Epigenetics and DNA Methylation (23 papers)Histone Deacetylase Inhibitors Research (13 papers)Cancer-related gene regulation (13 papers)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Nathan R. Rose
32 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 3.5k
- Cancer Research 863
- Genetics 378
- Oncology 254
- Genetics 237
Countries citing papers authored by Nathan R. Rose
This map shows the geographic impact of Nathan R. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan R. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan R. Rose more than expected).
Fields of papers citing papers by Nathan R. Rose
This network shows the impact of papers produced by Nathan R. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan R. Rose. The network helps show where Nathan R. Rose may publish in the future.
Co-authorship network of co-authors of Nathan R. Rose
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan R. Rose. A scholar is included among the top collaborators of Nathan R. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan R. Rose. Nathan R. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 266 | |
| 4 | 4 | |
| 5 | 34 | |
| 6 | Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity | 25 |
| 7 | 55 | |
| 8 | 61 | |
| 9 | 140 | |
| 10 | The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylasesbreakdown → | 762 |
| 11 | 304 | |
| 12 | 48 | |
| 13 | 51 | |
| 14 | 53 | |
| 15 | 173 | |
| 16 | 28 | |
| 17 | 76 | |
| 18 | 72 | |
| 19 | 136 | |
| 20 | 263 |
About Nathan R. Rose
Nathan R. Rose is a scholar working on Molecular Biology, Cancer Research and Biochemistry, having authored 32 papers that have together received 4.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (23 papers), Histone Deacetylase Inhibitors Research (13 papers) and Cancer-related gene regulation (13 papers). The work is most often cited by research in Cancer Research (863 citations), Molecular Biology (3.5k citations) and Genetics (237 citations). Nathan R. Rose has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Robert J. Klose, Christopher J. Schofield, M.A. McDonough, Oliver N. F. King, Akane Kawamura, Neil P. Blackledge, Udo Oppermann, Stanley S. Ng, Esther C. Y. Woon and Peter J. Ratcliffe. Their work appears in journals such as Nature, Chemical Society Reviews and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.